US market entry Convergence specializes in US market access and growth planning for life science companies, creating a direct sales opportunity to offer market entry strategy, regulatory navigation, and partnership development services to vendors seeking to enter or expand in the US healthcare market.

Nordics cross-sell With a footprint in the Nordics, there is a potential to upsell clients seeking dual-market expansion or global branding and digital transformation services, leveraging their network to facilitate partnerships between US and Nordic healthcare stakeholders.

Evidence-based connections Their core value is connecting hospital leaders, researchers, clinicians, and investors to accelerate adoption of innovations; a compelling angle to position executive briefings, advisory packs, and targeted outreach for medical devices, biotech, AI, and health tech solutions.

Digital stack leverage Existing tech stack (AWS, New Relic, AB Tasty, Snowplow, Microsoft 365) indicates readiness for data-driven marketing, analytics, and customer experience enhancements—sales opportunities include offering marketing automation, lifecycle analytics, and performance monitoring services.

Focused growth areas Target themes such as Women’s Health, Brain Health, Gut Microbiome, Healthcare Resilience, and value-based care innovations identify niche selling points for partnerships, pilots, co-development ventures, and grant-funded initiatives with healthcare providers and life science companies.